These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20586100)

  • 1. Surrogate end-points for treatment trials of hepatitis B virus.
    Griffiths PD
    Rev Med Virol; 2010 Jul; 20(4):199-201. PubMed ID: 20586100
    [No Abstract]   [Full Text] [Related]  

  • 2. Navigating the maze of hepatitis B treatments.
    Lok AS
    Gastroenterology; 2007 Apr; 132(4):1586-94. PubMed ID: 17408643
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of chronic hepatitis B with a combination of acyclovir and alpha-lymphoblastoid interferon.
    Schalm SW
    J Chemother; 1989 Jul; 1(4 Suppl):1112-4. PubMed ID: 16312795
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tenofovir, An antiviral agent with activity against HIV infections and hepatitis B].
    Taéron C
    Rev Infirm; 2009 Sep; (153):49-51. PubMed ID: 19771814
    [No Abstract]   [Full Text] [Related]  

  • 5. Introduction to 'Hepatitis B virus heterogeneity--a means to personalized care'.
    Bonino F;
    Antivir Ther; 2010; 15 Suppl 3():1-2. PubMed ID: 21041898
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
    Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
    Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of hepatitis B virus therapeutic agents using asialoglycoprotein receptor-based liver-specific targeting.
    Konishi M; Wu CH; Wu GY
    Methods Mol Med; 2004; 96():163-73. PubMed ID: 14762268
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication.
    Kim HJ; Yoo HS; Kim JC; Park CS; Choi MS; Kim M; Choi H; Min JS; Kim YS; Yoon SW; Ahn JK
    J Ethnopharmacol; 2009 Jul; 124(2):189-96. PubMed ID: 19409970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.
    Ben-Ari Z; Zemel R; Kazetsker A; Fraser G; Tur-Kaspa R
    Am J Gastroenterol; 1999 Mar; 94(3):663-7. PubMed ID: 10086648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Residual hepatitis B virus particles in liver transplant recipients receiving lamivudine: PCR quantitation of HBV DNA and ELISA of preS1 antigen.
    Petit MA; Buffello-Le Guillou D; Roche B; Dussaix E; Duclos-Vallée JC; Féray C; Samuel D
    J Med Virol; 2001 Nov; 65(3):493-504. PubMed ID: 11596084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lamivudine treatment consensus from relative experts].
    Lamivudine Clinical Practice Group
    Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):157-8. PubMed ID: 12108391
    [No Abstract]   [Full Text] [Related]  

  • 12. A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.
    Mazur W; Król F; Cianciara J; Nazzal K; Gładysz A; Juszczyk J; Bolewska B; Adamek J; Czajka B; Swietek K; Kryczka W; Gonciarz Z
    Med Sci Monit; 2002 Apr; 8(4):CR257-62. PubMed ID: 11951067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro models for studying hepatitis B virus drug resistance.
    Zoulim F
    Semin Liver Dis; 2006 May; 26(2):171-80. PubMed ID: 16673295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatological update (7). 2 different phases of chronic hepatitis B--2 different methods of treatment?].
    Juszczyk J
    Pol Tyg Lek; 1987 Oct; 42(43):1365-8. PubMed ID: 3328179
    [No Abstract]   [Full Text] [Related]  

  • 15. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral efficacy against hepatitis B virus replication of oleuropein isolated from Jasminum officinale L. var. grandiflorum.
    Zhao G; Yin Z; Dong J
    J Ethnopharmacol; 2009 Sep; 125(2):265-8. PubMed ID: 19580857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B escape mutant reactivation in a renal transplant patient.
    Le Pendeven C; Cuzon G; Fontaine H; Zatla F; Schneider V; Amiel C; Khayat R; Nicolas JC; Soussan P
    J Clin Virol; 2007 Sep; 40(1):74-6. PubMed ID: 17652016
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis B virus-related membranous nephropathy treated with entecavir.
    Ikee R; Ishioka K; Oka M; Maesato K; Moriya H; Hidaka S; Ohtake T; Kobayashi S
    Nephrology (Carlton); 2010 Mar; 15(2):266. PubMed ID: 20470290
    [No Abstract]   [Full Text] [Related]  

  • 19. Natural history of hepatitis B in perinatally infected carriers.
    Boxall EH; Sira J; Standish RA; Davies P; Sleight E; Dhillon AP; Scheuer PJ; Kelly DA
    Arch Dis Child Fetal Neonatal Ed; 2004 Sep; 89(5):F456-60. PubMed ID: 15321970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of multi-drug resistant hepatitis B virus during sequential therapy.
    Yim HJ; Hussain M; Liu Y; Wong SN; Fung SK; Lok AS
    Hepatology; 2006 Sep; 44(3):703-12. PubMed ID: 16941700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.